BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27619078)

  • 1. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy.
    Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S
    ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
    Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
    Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and
    Wang J; Liu Q; Yang L; Xia X; Zhu R; Chen S; Wang M; Cheng L; Wu X; Wang S
    J Biomed Nanotechnol; 2017 Dec; 13(12):1631-1646. PubMed ID: 29490752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.
    Dizaj SM; Kouhsoltani M; Pourreza K; Sharifi S; Abdolahinia ED
    Pharm Nanotechnol; 2024; 12(3):269-275. PubMed ID: 37594097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
    Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
    Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
    Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
    Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery.
    Fang XB; Zhang JM; Xie X; Liu D; He CW; Wan JB; Chen MW
    Int J Pharm; 2016 Apr; 502(1-2):28-37. PubMed ID: 26784981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect.
    Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D
    Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells.
    Zeighamian V; Darabi M; Akbarzadeh A; Rahmati-Yamchi M; Zarghami N; Badrzadeh F; Salehi R; Mirakabad FS; Taheri-Anganeh M
    Artif Cells Nanomed Biotechnol; 2016; 44(2):735-42. PubMed ID: 25819738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery.
    Tian Z; Xu Y; Zhu Y
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():452-459. PubMed ID: 27987731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
    Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
    Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
    Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.